Advances in antibody engineering for rheumatic diseases

Nature Reviews. Rheumatology
Anja S Schmid, Dario Neri

Abstract

The advent of biologic therapies, particularly antibody therapeutics, has revolutionized the pharmacological treatment of many rheumatic diseases. Antibody discovery began with the immunization of mice for the production of rodent immunoglobulins, but advances in protein and genetic engineering have now made it possible to generate fully human antibodies, which are better tolerated by patients. For most clinical applications in rheumatology, antibodies have been used as blocking agents capable of neutralizing the function of pro-inflammatory proteins, such as TNF. The latest strategies involve antibody products armed with effector moieties, such as anti-inflammatory drugs or cytokines, or antibody products that are specific for multiple targets for the selective inhibition of inflammation at sites of disease. Antibodies are some of the best-selling drugs in the world, and with further advances in antibody development, engineering of armed antibodies and bispecific products will have an important role in the treatment of rheumatic diseases.

References

Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S L MorrisonV T Oi
Jan 1, 1994·Annual Review of Immunology·G WinterH R Hoogenboom
Jun 1, 1996·The Journal of Infectious Diseases·S M OpalC Donsky
Jan 1, 1996·Journal of Clinical Laboratory Analysis·R A Reisfeld, S D Gillies
Sep 1, 1996·Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)·S L Smith
Feb 1, 1996·Immunotechnology : an International Journal of Immunological Engineering·A M WuJ E Shively
Jul 14, 1998·Nature Biotechnology·A M MerchantP Carter
Feb 27, 2001·Journal of Immunological Methods·P Carter
Feb 27, 2001·Journal of Immunological Methods·M L Penichet, S L Morrison
Jan 2, 2003·Nature Reviews. Drug Discovery·Ole Henrik Brekke, Inger Sandlie
Mar 17, 2004·Annals of the Rheumatic Diseases·J S Smolen
Jul 21, 2004·Journal of Immunological Methods·Per-Ake Nygren, Arne Skerra
Jun 2, 2005·Nature Reviews. Cancer·Dario Neri, Roy Bicknell
Oct 8, 2005·Nature Biotechnology·H Kaspar BinzAndreas Plückthun
Oct 13, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sophia HoberMartin Linhult
Jan 31, 2007·Arthritis Research & Therapy·Eveline TrachselDario Neri
Oct 9, 2007·Nature Biotechnology·Christopher Thomas Scott
Feb 1, 2008·Nature Methods·UNKNOWN Structural Genomics ConsortiumKristin C Gunsalus
Apr 25, 2009·Arthritis Research & Therapy·Andrea Rubbert-Roth, Axel Finckh
Jun 9, 2009·Current Opinion in Chemical Biology·Michaela Gebauer, Arne Skerra
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sven LétourneauOnur Boyman
Mar 23, 2010·Nature Reviews. Drug Discovery·Trevor T HanselAndrew J T George
Jul 6, 2011·Current Opinion in Biotechnology·John LöfblomStefan Ståhl
Nov 1, 2011·Nature Reviews. Drug Discovery·David Holmes
Dec 21, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefanie KoristkaMichael Bachmann
Mar 29, 2012·MAbs·Roland E Kontermann
May 23, 2012·The Journal of Pain : Official Journal of the American Pain Society·Darrell J Gaskin, Patrick Richard
May 4, 2013·Biochimica Et Biophysica Acta·Darrell SleepLeslie R Evans
Jun 5, 2013·Nanomedicine·Gholamreza Hassanzadeh-GhassabehSerge Muyldermans
Sep 12, 2013·Protein Expression and Purification·David L HackerFlorian M Wurm
Dec 10, 2013·FEBS Letters·Ashok D Bandaranayake, Steven C Almo
Aug 6, 2014·Proceedings of the National Academy of Sciences of the United States of America·Teresa HemmerleDario Neri
Sep 6, 2014·Journal of Dermatological Science·Teresa HemmerleDario Neri
Feb 24, 2015·Journal of the American Chemical Society·Rongsheng E WangPeter G Schultz
Mar 3, 2015·Drug Discovery Today·Roland E Kontermann, Ulrich Brinkmann
Mar 15, 2015·Molecular Immunology·E Sally WardRaimund J Ober
Apr 9, 2015·Reproductive Sciences·Federica QuattronePaola Panina-Bordignon
May 8, 2015·Oncoimmunology·Stefanie KoristkaMichael P Bachmann
Jul 8, 2015·Nature Reviews. Rheumatology·Chang-Fu KuoMichael Doherty

❮ Previous
Next ❯

Citations

Dec 12, 2019·Scientific Reports·Julie GastonPierre-François Berne
Apr 8, 2020·Journal of Immunology Research·Bin WangGuixiu Shi
Dec 31, 2020·Biomolecules·Jiří BalounLadislav Šenolt
Feb 3, 2021·Nature Reviews. Rheumatology·Christopher D BuckleyKim S Midwood
May 4, 2021·Frontiers in Pharmacology·Mengda Xu, Jiangping Song
May 25, 2021·Frontiers in Immunology·Jiabing MaCheng Qian
Jul 6, 2021·Biotechnology and Bioprocess Engineering : BBE·Seung Hyun Kang, Chang-Han Lee
Oct 7, 2021·Expert Opinion on Biological Therapy·Bénédicte CaronLaurent Peyrin-Biroulet
Jan 28, 2022·Expert Opinion on Pharmacotherapy·Egle RamelyteReinhard Dummer

❮ Previous
Next ❯

Methods Mentioned

BETA
phage display
transgenic
ion-exchange chromatography
glycosylation

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

© 2022 Meta ULC. All rights reserved